Two lot numbers, 634534e and 634584a, were provided for this incident.However, these lot numbers do not exist for the reported catalog # 328838.Therefore, a manufacture date and an expiration date are unknown.A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.(b)(4).
|
Results: a review of the device history record was completed for batch # 6347584 the dhr shows there were two incidents noted during completion of the dhr/qn review for unrelated documentation issues.Customer returned (58) 3/10cc, 8mm, 30g syringes in open poly bags from lot # 6347584.Customer states that after withdrawing insulin, the drug inside insulin syringe became black as it should be clear.Nineteen syringes were returned with approximately 16 units of a cloudy liquid inside the barrel.All returned syringes were examined and 52 out of 58 samples exhibited dark material smeared on the surface of the barrel.No dark material was observed in the barrels.A small portion of this material was removed from the sample and prepared for ftir spectral analysis.The spectral analysis suggests that this material has components similar to those of scale print.Conclusion: bd was able to duplicate or confirm the customer¿s indicated failure (smeared ink on surface of barrel) possible root cause is attributed to pad swelling on the mandril during the printing process.As the pads are used, they gradually swell and can cause this type of "smear" or "smudge affect.A problem solving team has been tasked with improving print quality on all production lines within the plant.The team is systematically assessing and addressing each printer individually for improvements.The (b)(4) plant is currently working on continuous improvement efforts surrounding print defects found within the plant and their associated root cause(s).Capa (b)(4) was initiated to address such issues at this time.
|